+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sulfamethoxazole"

Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Sulphonamides Market - Product Thumbnail Image

Global Sulphonamides Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Sulfamethoxazole is an antibiotic drug used to treat a variety of bacterial infections. It is a sulfonamide, a type of synthetic antibacterial agent that is derived from para-aminobenzoic acid. It is used to treat urinary tract infections, bronchitis, and other respiratory infections, as well as some skin and soft tissue infections. It is also used to prevent and treat certain types of pneumocystis pneumonia in people with weakened immune systems. Sulfamethoxazole is often used in combination with trimethoprim, another antibiotic, to treat a variety of infections. Sulfamethoxazole is available in both generic and brand-name forms. It is available as a tablet, an oral suspension, and an intravenous injection. It is also available in combination with other antibiotics, such as trimethoprim, to treat certain infections. The sulfamethoxazole market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major companies in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more